Dabigatran etexilate
Dabigatran etexilate
About this item
Full title
Dabigatran etexilate
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature reviews. Drug discovery, 2008-07, Vol.7 (7), p.557-558
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
In March 2008, the European Commission granted marketing authorization for dabigatran etexilate (Pradaxa; Boehringer Ingelheim), a direct thrombin inhibitor, for the prevention of venous thromboembolic events in patients who have undergone total hip- or knee-replacement surgery.
Dabigatran etexilate
Alternative Titles
Full title
Dabigatran etexilate
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_gup_ub_gu_se_82016
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_82016
Other Identifiers
ISSN
1474-1776,1474-1784
E-ISSN
1474-1784
DOI
10.1038/nrd2622
